Order Article Reprints

Cunha LSD, Farias IM, Nogueira BMD, Machado CB, Pessoa FMCDP, Oliveira DDS, de Morais GP, Thé AP, Thé PMP, Moraes Filho MOD, et al. Epigallocatechin Gallate as a Targeted Therapeutic Strategy Against the JAK2V617F Mutation: New Perspectives for the Treatment of Myeloproliferative Neoplasms and Acute Myeloid Leukemia. International Journal of Translational Medicine. 2025; 5(3):43. https://doi.org/10.3390/ijtm5030043

Cunha, Leidivan Sousa Da, Isabelle Magalhães Farias, Beatriz Maria Dias Nogueira, Caio Bezerra Machado, Flávia Melo Cunha De Pinho Pessoa, Deivide De Sousa Oliveira, Guilherme Passos de Morais, André Pontes Thé, Patrícia Maria Pontes Thé, Manoel Odorico De Moraes Filho, and et al. 2025. "Epigallocatechin Gallate as a Targeted Therapeutic Strategy Against the JAK2V617F Mutation: New Perspectives for the Treatment of Myeloproliferative Neoplasms and Acute Myeloid Leukemia" International Journal of Translational Medicine 5, no. 3: 43. https://doi.org/10.3390/ijtm5030043

Cunha, L. S. D., Farias, I. M., Nogueira, B. M. D., Machado, C. B., Pessoa, F. M. C. D. P., Oliveira, D. D. S., de Morais, G. P., Thé, A. P., Thé, P. M. P., Moraes Filho, M. O. D., Moraes, M. E. A. D., & Moreira-Nunes, C. A. (2025). Epigallocatechin Gallate as a Targeted Therapeutic Strategy Against the JAK2V617F Mutation: New Perspectives for the Treatment of Myeloproliferative Neoplasms and Acute Myeloid Leukemia. International Journal of Translational Medicine, 5(3), 43. https://doi.org/10.3390/ijtm5030043